Clinical Trial Update: A Study of XW003 in Obese Participants With Obstructive Sleep Apnea But Not Receive Positive Airway Pressure Therapy [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial evaluating XW003 in obese participants with obstructive sleep apnea who are not using positive airway pressure therapy; the study is cu…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Obesity
• Obstructive Sleep Apnea

Drugs mentioned

• XW003

Snippet

Sponsor: Hangzhou Sciwind Biosciences Co., Ltd. | Conditions: OSA - Obstructive Sleep Apnea, Obesity | Phase 3 | Status: RECRUITING